Ligand Pharmaceuticals | LGND - نسبة السعر إلى الأرباح





Pe تغيير تاريخ
Amgen 19.84 5.47 2026-03
Anika Therapeutics 47.54 27.2 2024-06
Baxter International 86 68.9 2025-12
Bristol-Myers Squibb 9.08 0.2 2026-03
Eli Lilly 40.27 0.06 2026-03
Enviri Corporation 121.21 92.59 2023-06
Gilead Sciences 17.7 2.07 2026-03
GlaxoSmithKline 14.87 3.72 2026-03
Glaxosmithkline 11.66 0.28 2025-12
Intrexon 7.54 221.44 2021-12
Ionis Pharmaceuticals 396.15 79.28 2022-09
Ligand Pharmaceuticals 56.5 26.8 2026-03
Merck 16.52 2.6 2026-03
Pacira 38.58 14.1 2026-03
Pfizer 9.32 5.16 2026-03
Rigel Pharmaceuticals 8.61 8.4 2025-03
Veracyte 24.89 20.41 2026-03